Health News Roundup: Key Events and Developments

Current health news highlights include: Indonesia court rulings on toxic cough syrup, AstraZeneca's UK vaccine production move threat, Gaza's first polio case in 25 years, WHO’s early mpox vaccine talks, updated COVID-19 vaccine approval, Germany’s mpox vaccine donation consideration, Ozempic’s 2027 Medicare negotiations, South Korea COVID-19 surge risks, Evolent Health's potential sale, and Sudan’s cholera outbreak.

Key health news currently making headlines include several significant developments. An Indonesian court has held drugmakers accountable for toxic cough syrup causing acute kidney injury among children. AstraZeneca is considering moving its vaccine production from the UK to the US amidst deadlocked state aid talks. In Gaza, a 10-month-old baby has been paralyzed by type 2 polio, marking the first such case in 25 years, prompting urgent calls for vaccination by the WHO.

The World Health Organization is allowing partners to purchase mpox vaccines before official approval to expedite the response to Africa's outbreak. The US FDA has approved updated COVID-19 vaccines from Pfizer and Moderna in time for the fall vaccination push. Meanwhile, Germany is contemplating donating its remaining mpox vaccine stocks. Wall Street analysts predict Ozempic will be a major focus in the 2027 Medicare drug negotiations.

South Korea's medical sector warns of possible ER closures due to a combination of increasing COVID-19 cases and striking trainee doctors. Evolent Health is in discussions for a potential sale after receiving takeover interest. Finally, Sudan faces a deadly cholera outbreak exacerbated by the ongoing conflict and rainy season.